Kidney Disease News and Research

RSS

New insights into how the brain can induce diabetes remission in rodents

In rodents with type 2 diabetes, a single surgical injection of a protein called fibroblast growth factor 1 can restore blood sugar levels to normal for weeks or months. Yet how this growth factor acts in the brain to generate this lasting benefit has been poorly understood.

7 Sep 2020

MIS-C linked to COVID-19 damages children's hearts

Multisystem inflammatory syndrome in children (MIS-C), believed to be linked to COVID-19, damages the heart to such an extent that some children will need lifelong monitoring and interventions, said the senior author of a medical literature review published Sept. 4 in EClinicalMedicine, a journal of The Lancet.

5 Sep 2020

Researchers identify biomarkers associated with bacterial infection mortality

David Gonzalez's "a-ha" moment came when a physician-colleague, George Sakoulas, MD, shared with him one of the biggest problems faced in clinical practice: How long it takes to diagnose a patient.

4 Sep 2020

Ellipsys Vascular Access System reduces time for dialysis treatments

The Ellipsys Vascular Access System reduces the time before patients with kidney failure can start lifesaving dialysis treatments, while requiring fewer secondary procedures, according to a new study led by interventional radiologist Jeffrey Hull, M.D., of Richmond Vascular Center.

3 Sep 2020

Why Black aging matters, too

Old. Chronically ill. Black. People who fit this description are more likely to die from COVID-19 than any other group in the country.

3 Sep 2020

New grant supports research into diabetic kidney disease and COVID-19

Mater and University of Queensland Researcher Dr Mitchell Sullivan has been awarded a 2020 Advance Queensland Industry Research Fellowship from the Queensland Government to fund his research into diabetic kidney disease and COVID-19.

3 Sep 2020

Active lifestyle choices can lower the risk of chronic kidney disease

Active lifestyle choices such as eating vegetables, exercising and quitting smoking can reduce the risk of chronic kidney disease, a new study led by researchers at Karolinska Institutet in Sweden and Griffith University in Australia, reports.

2 Sep 2020

Majority of U.S. COVID-19 fatalities had underlying medical conditions

Early on in the coronavirus disease (COVID-19) pandemic, there was little data on the virus and how it affects the body. As the virus spread across the globe, data showed that some people were at a higher risk of developing severe disease and dying from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

31 Aug 2020

SGLT2 inhibitors can slow CKD progression

850 million people worldwide are affected by chronic kidney disease (CKD) - a worrying figure, and one that continues to rise.

31 Aug 2020

DAPA-CKD trial shows dapagliflozin reduces risk of chronic kidney disease

Dapagliflozin reduces the risk of kidney failure, death from cardiovascular causes or heart failure hospitalization and all-cause mortality in chronic kidney disease patients with or without type 2 diabetes.

31 Aug 2020

Cat antiviral that inhibits SARS-CoV-2 fast-tracked for human clinical trials

Now, a team of researchers at the University of Alberta in Canada has identified viral inhibitors that they claim are potential candidates as a treatment for COVID-19. The team is set to launch clinical trials of the drug that is used as a treatment for a type of coronavirus in cats.

31 Aug 2020

Dialysis patients have higher risk for SARS-CoV-2 infection, study suggests

It's widely known that the causative agent for COVID-19, the SARS-CoV-2 virus, can spread rapidly among residents in nursing homes and other long-term care facilities, leading to high numbers of cases and deaths in a very vulnerable population.

25 Aug 2020

Antihypertensives improve COVID-19 survival rates

Previous studies have also linked hypertension to severe coronavirus disease (COVID-19). Now, a new study by researchers at the University of East Anglia's Norwich Medical School has found that the risk of severe COVID-19 and death was reduced for patients with high blood pressure who were taking Angiotensin-Converting Enzyme inhibitors (ACEi) or Angiotensin Receptor Blockers (ARB).

24 Aug 2020

VUMC receives $34 million grant for nationwide convalescent plasma study

Vanderbilt University Medical Center has been awarded a one-year, $34-million grant by the National Center for Advancing Translational Sciences, part of the National Institutes of Health, to conduct a nationwide study of "convalescent plasma" as a treatment for COVID-19.

21 Aug 2020

Researchers reproduce the pathogenesis of hereditary kidney disease from human iPS cells

Joint research, led by Kumamoto University in Japan, has successfully reproduced the pathogenesis of autosomal dominant polycystic kidney disease (ADPKD) from human iPS cells in vitro.

21 Aug 2020

Ciliary proteins play vital role in cardiovascular functions and genetic diseases

Research from Chapman University provides new insight into the characteristics of crucial proteins within the ciliary membrane that play vital roles in human genetic diseases and cardiovascular functions.

20 Aug 2020

SARS-CoV-2 viral load predicts risk of death

As the coronavirus pandemic evolved, there have been many developments in testing for the SARS-CoV-2 viral load in patients. Now, a team of researchers at the Icahn School of Medicine at Mount Sinai, New York, has found that the SARS-CoV-2 viral load can predict mortality in patients with coronavirus disease (COVID-19).

13 Aug 2020

Smoking and vaping significantly increase risk of COVID-19 in teens and young adults

Now, a new study published in the Journal of Adolescent Health shows that teens and young adults may have a heightened risk of COVID-19 if they vape or smoke cigarettes. Cigarette smokers are seven times more likely to be infected with SARS-CoV-2. Meanwhile, people who vape are five times more likely to be diagnosed with the viral infection.

11 Aug 2020

Proteinuria reduction slows kidney decline in patients with focal segmental glomerulosclerosis

Reducing the amount of protein in the urine of patients with focal segmental glomerulosclerosis (FSGS), a rare disease in which scar tissue forms on the parts of the kidneys that filter waste from the blood, can significantly slow declines in kidney function and extend time before patients' kidneys fail, a new analysis by a Children's National Hospital researcher and her colleagues shows.

10 Aug 2020

Non-fasting blood test can help accurately identify youth at risk for diabetes and related risks

A simple blood test that does not require overnight fasting has been found to be an accurate screening tool for identifying youth at risk for type 2 diabetes and heart disease risk later in life, according to a study from researchers at the Johns Hopkins Bloomberg School of Public Health.

10 Aug 2020

Kidney Disease News and Research

New insights into how the brain can induce diabetes remission in rodents

MIS-C linked to COVID-19 damages children's hearts

Researchers identify biomarkers associated with bacterial infection mortality

Ellipsys Vascular Access System reduces time for dialysis treatments

Why Black aging matters, too

New grant supports research into diabetic kidney disease and COVID-19

Active lifestyle choices can lower the risk of chronic kidney disease

Majority of U.S. COVID-19 fatalities had underlying medical conditions

SGLT2 inhibitors can slow CKD progression

DAPA-CKD trial shows dapagliflozin reduces risk of chronic kidney disease

Cat antiviral that inhibits SARS-CoV-2 fast-tracked for human clinical trials

Dialysis patients have higher risk for SARS-CoV-2 infection, study suggests

Antihypertensives improve COVID-19 survival rates

VUMC receives $34 million grant for nationwide convalescent plasma study

Researchers reproduce the pathogenesis of hereditary kidney disease from human iPS cells

Ciliary proteins play vital role in cardiovascular functions and genetic diseases

SARS-CoV-2 viral load predicts risk of death

Smoking and vaping significantly increase risk of COVID-19 in teens and young adults

Proteinuria reduction slows kidney decline in patients with focal segmental glomerulosclerosis

Non-fasting blood test can help accurately identify youth at risk for diabetes and related risks

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News